PMID- 37234921 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240214 IS - 2296-889X (Print) IS - 2296-889X (Electronic) IS - 2296-889X (Linking) VI - 10 DP - 2023 TI - MALDI-TOF Mass Spectrometry for interrogating ubiquitin enzymes. PG - 1184934 LID - 10.3389/fmolb.2023.1184934 [doi] LID - 1184934 AB - The attachment of ubiquitin to a substrate (ubiquitination or ubiquitylation) impacts its lifetime and regulates its function within the cell. Several classes of enzymes oversee the attachment of ubiquitin to the substrate: an E1 activating enzyme that makes ubiquitin chemically susceptible prior to the following stages of conjugation and ligation, respectively mediated by E2 conjugating enzymes (E2s) and E3 ligases (E3s). Around 40 E2s and more than 600 E3s are encoded in the human genome, and their combinatorial and cooperative behaviour dictate the tight specificity necessary for the regulation of thousands of substrates. The removal of ubiquitin is orchestrated by a network of about 100 deubiquitylating enzymes (DUBs). Many cellular processes are tightly controlled by ubiquitylation, which is essential in maintaining cellular homeostasis. Because of the fundamental role(s) of ubiquitylation, there is an interest in better understanding the function and specificity of the ubiquitin machinery. Since 2014, an expanding array of Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) Mass Spectrometry (MS) assays have been developed to systematically characterise the activity of a variety of ubiquitin enzymes in vitro. Here we recapitulate how MALDI-TOF MS aided the in vitro characterization of ubiquitin enzymes and the discovery of new and unexpected of E2s and DUBs functions. Given the versatility of the MALDI-TOF MS approach, we foreseen the use of this technology to further expand our understanding of ubiquitin and ubiquitin-like enzymes. CI - Copyright (c) 2023 De Cesare. FAU - De Cesare, Virginia AU - De Cesare V AD - MRC Protein Phosphorylation and Ubiquitylation Unit, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee, United Kingdom. LA - eng GR - MR/V025759/1/MRC_/Medical Research Council/United Kingdom PT - Journal Article DEP - 20230509 PL - Switzerland TA - Front Mol Biosci JT - Frontiers in molecular biosciences JID - 101653173 PMC - PMC10206504 OTO - NOTNLM OT - E2 conjugating enzyme OT - E3 ligase OT - HECT E3 ligase OT - Matrix-assisted laser desorption/ionization time-of-flight Mass-Spectrometry (MALDI-TOF MS) OT - RBR E3 ligase, RING E3 ligase OT - deubiquinating enzymes OT - non-lysine ubiquitination OT - ubiquitin (Ub) COIS- The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2023/05/26 19:14 MHDA- 2023/05/26 19:15 PMCR- 2023/01/01 CRDT- 2023/05/26 12:19 PHST- 2023/03/12 00:00 [received] PHST- 2023/04/13 00:00 [accepted] PHST- 2023/05/26 19:15 [medline] PHST- 2023/05/26 19:14 [pubmed] PHST- 2023/05/26 12:19 [entrez] PHST- 2023/01/01 00:00 [pmc-release] AID - 1184934 [pii] AID - 10.3389/fmolb.2023.1184934 [doi] PST - epublish SO - Front Mol Biosci. 2023 May 9;10:1184934. doi: 10.3389/fmolb.2023.1184934. eCollection 2023.